UCLA Invents Newsletter
Newsletter published by: UCLA OIP-ISR February 2015




March 06, 2015
FirstFridays @ OIP
Topic:  "NSF iCorps Program at UCLA"
Speaker:  Schaffer Grimm, Institute for Technology Advancement, UCLA

March 10, 2015
3rd Annual UCLA Medical Device Industry Partnering Conference

More Events


CohBar Logo

UCLA Licensee CohBar, Inc. Completes $11.25 IPO
Pasadena, California - CohBar, Inc., a biotech company focused on developing mitochondiral-derived peptides-based therapeutics, announced that it completed an Initial Public Offering (IPO) on January 6, 2015 of 11,250,000 units at a price of US$1.00 per unit, providing gross proceeds of US$11,250,000.
Kythera Logo

FDA Considers Kythera’s ATX-101 for Chin Fat Treatment
KYTHERA Biopharmaceuticals recently announced the Dermatology and Ophthalmic Drugs Advisory Committee of the FDA is scheduled to review KYTHERA’s New Drug Application (NDA) for ATX-101 (deoxycholic acid) for improvement in the appearance of moderate to severe submental fullness.
NeuroInDx Logo

NeuroInDx Unveils New Product Based on UCLA IP
The original idea was conceived and patented at UCLA, and further developed by NeuroInDx. UnipicKTM can be used as an add-on to nearly any inverted microscope for collecting single or multiple cells from culture dishes and slides, as well as for microdissecting subanatomical regions from tissue sections.
UCLA Anderson Logo

UCLA Anderson Embraces Tech Boom, Entrepreneurs
FORTUNE Magazine: UCLA’s Anderson has gone through a transformation in recent years, becoming more closely tied to movements within the tech industries in L.A., Silicon Valley, and Seattle. The percentage of MBAs going into tech from UCLA has more than doubled in the past four years, eclipsing the 20.4% who took finance jobs and the 14.2% who went into consulting.

Intellectual Property Announcements

New U.S. Patents Awarded

  • 8,946,454 - Chemical framework compositions and methods of use  | J. Stoddart, et al.
  • 8,938,115 - Systems and methods for data fusion mapping estimation  | A. Bertozzi, et al.
  • 8,933,203 - Vault and vault-like carrier molecules  | L. Rome, et al.
  • 8,924,881 - Drill down clinical information dashboard  | N. Martin, et al.
  • 8,920,807 - Vault complexes for cytokine delivery  | S. Dubinett, et al.
  • 8,917,562 - Body voltage sensing based short pulse reading circuit  | D. Markovic, et al.


New UCLA Technologies Available for Licensing



    UCLA Medical Device Industry Partnering Conf.

    March 10, 2015 - 3rd Annual UCLA Medical Device Industry Partnering Conference - Register Now
    UCLA's 3rd Annual Medical Device Industry Partnering Conference provides a unique opportunity for UCLA inventors, investors, and industry executives to establish new relationships for furthering innovation. The event features industry panels, startup pitches, and provides ample time for networking.
    Previous Issue - UCLA Invents
    • 2014 Roundup: UCLA Startup Funding and IP Licensing Highlights
    • Kite Pharma, Amgen Forge $1B+ Cancer Immunotherapy Pact
    • UCLA Startup NeuroSigma Granted FDA HUD Designation
    • In March! UCLA Med Device Industry Partnering Conference
    UCLA TechMatch Program for
    Startups and Established Companies

    Customized, automated service matches UCLA innovation with
    industry research and technology licensing interests.  Subscribe today.

    UCLA Invents Newsletter, Vol. 3, No. 6

    How to Subscribe

    Send editorial comments and corrections to:  
    Bob Nidever,  bnidever@research.ucla.edu

    Contributors: Neil Bajpayee, Tara Kamin

    UCLA Invents is published by the UCLA Office of Intellectual Property & Industry Sponsored Research
    11000 Kinross Ave., Suite 200 | Los Angeles, CA 90095 | tel. 310-794-0558 | http://oip.ucla.edu

    Copyright © 2014 The Regents of the University of California. All Rights Reserved.

    Share this